Efficacy and safety of Deferasirox (Exjade) in reducing cardiac iron in patients with β-Thalassemia major : results from the cardiac substudy of the EPIC trial / D. Pennell, J.B. Porter, M.D. Cappellini, C.K. Li, Y. Aydinok, C.L. Lee, A. Kattamis, G. Smith, D. Habr, G. Domokos, A. Hmissi, A. Taher. - In: BLOOD. - ISSN 0006-4971. - 112:11(2008 Nov), pp. 1318-1318. ((Intervento presentato al 50. convegno ASH Fiftieth annual meeting and exposition tenutosi a San Francisco, USA nel 2008.
Efficacy and safety of Deferasirox (Exjade) in reducing cardiac iron in patients with β-Thalassemia major : results from the cardiac substudy of the EPIC trial
M.D. Cappellini;
2008
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
